Mismatch repair deficiency in ovarian cancer — Molecular characteristics and clinical implications
- 1 February 2014
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 132 (2), 506-512
- https://doi.org/10.1016/j.ygyno.2013.12.003
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profilingThe Journal of Pathology, 2013
- Differential diagnosis and clinical relevance of ovarian carcinoma subtypesExpert Review of Obstetrics & Gynecology, 2013
- Germline BRCA1 and BRCA2 Mutations in Ovarian CancerObstetrics & Gynecology, 2012
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupJournal of Clinical Oncology, 2012
- Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and TreatmentRadioGraphics, 2011
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals Of Oncology, 2010
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian CarcinomasInternational Journal of Gynecological Pathology, 2010
- Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, CanadaJNCI Journal of the National Cancer Institute, 2006
- The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial OriginInternational Journal of Gynecological Pathology, 2004
- Hereditary Ovarian CancerInternational Journal of Gynecological Pathology, 1992